Search / com.coverage-rights/coverage-rights
coverage-rights
R0· no sign-inInsurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups.
v1.1.0 · active · website · descriptor JSON · versions
Search / com.coverage-rights/coverage-rights
R0· no sign-inInsurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups.
v1.1.0 · active · website · descriptor JSON · versions
{
"mcpServers": {
"coverage-rights": {
"type": "http",
"url": "https://www.coverage-rights.com/api/mcp"
}
}
}claude mcp add --transport http coverage-rights https://www.coverage-rights.com/api/mcp[mcp_servers.coverage-rights]
url = "https://www.coverage-rights.com/api/mcp"
{
"$schema": "https://opencode.ai/config.json",
"mcp": {
"coverage-rights": {
"type": "remote",
"url": "https://www.coverage-rights.com/api/mcp",
"enabled": true
}
}
}{
"mcpServers": {
"coverage-rights": {
"type": "http",
"url": "https://www.coverage-rights.com/api/mcp"
}
},
"deeplink": "cursor://anysphere.cursor-deeplink/mcp/install?name=coverage-rights&config=eyJ0eXBlIjoiaHR0cCIsInVybCI6Imh0dHBzOi8vd3d3LmNvdmVyYWdlLXJpZ2h0cy5jb20vYXBpL21jcCJ9"
}{
"servers": {
"coverage-rights": {
"type": "http",
"url": "https://www.coverage-rights.com/api/mcp"
}
}
}{
"mcpServers": {
"coverage-rights": {
"httpUrl": "https://www.coverage-rights.com/api/mcp"
}
}
}extensions:
"coverage-rights":
enabled: true
name: "coverage-rights"
type: streamable_http
uri: "https://www.coverage-rights.com/api/mcp"
timeout: 300
protocol.modernnewest supported version is 2025-11-25; 2026-07-28 not supported, older versions are deprecated until 2027-07-28protocol.statelessonly applies to 2026-07-28 serversprotocol.transportstreamable HTTPprotocol.list_ttlonly applies to 2026-07-28 serversauth.prm, auth.as_metadata, auth.cimdno remote uses OAuthauth.secret_in_urlno templated URLtools.descriptionsevery tool has a descriptiontools.description_lengthdescriptions are concisetools.schemasevery tool has an object input schematools.annotations9 of 9 tools declare readOnlyHint or destructiveHinttools.directory_hintsevery tool declares readOnlyHint, destructiveHint, idempotentHint and openWorldHinttools.token_costabout 1,835 tokens to load every tooltools.api_dumptools are not a one-to-one API dumpstability.changesno tool changes in 30 daysstability.rug_pullno tool changed its meaning under the same namedeps.known_vulns, deps.mcp_sdk_version, deps.resolvableno npm or PyPI packageNo tool definition changes recorded. A server's first observation is its baseline; later probes record what changes.
Checks run on what our credential-free, read-only probes observe; tools are never called and no code audit is performed. How it is computed.
+dns-namespace +website +reachable +uptime-100% ~updated-86d-ago -no-repository
Derived from observable signals (official registry feed and our own credential-free probes); no code audit performed. How it is computed.
| remote | auth | reachable | uptime 30d | p50 | protocol | last ok |
|---|---|---|---|---|---|---|
https://www.coverage-rights.com/api/mcp streamable-http | none | yes | 100% | 223 ms | 2025-11-25 | 2026-10-20 |
get_appeal_rightsread-only | Deterministically resolve the governing appeal route, missing facts, filing recipient, deadlines, current external-review status, and verified grounds. Distinguishes Original Medicare, Medicare Advantage medical benefits, Part D pharmacy benefits, employer funding/governance, ACA, Medicaid, FEHB, TRICARE, and unknown coverage; unsupported or ambiguous routes fail closed. |
get_condition_outcomesread-only | External-review outcomes for a medical condition: how often insurance denials involving this condition were overturned, plus the most-fought treatments for it. |
get_drug_playbookread-only | Drug-specific denial patterns and appeal strategy for the medications plans fight hardest over: GLP-1s (Wegovy, Zepbound, Mounjaro, Ozempic, Saxenda) and IBD biologics (Humira, Skyrizi, Stelara, Entyvio, Remicade, Rinvoq). Returns FDA-approved indications stated conservatively, why plans deny that specific drug, what winning appeals argue, and the step-therapy exception framing — plus the published external-review record for the drug when the corpus has it. Accepts a brand or generic name. |
get_insurer_metricsread-only | Get an insurer's verified CY2025 prior-authorization metrics (denial rate, appeal overturn rate, decision times) from its own CMS-0057-F disclosure, plus contract/plan-level rows where collected. Includes source URLs and scope notes. |
get_state_external_reviewread-only | How a state's external review process works: filing deadline, regulator contact, and key facts. Verified detail currently covers 10 states (CA, TX, FL, NY, PA, IL, OH, GA, NC, MI); other states return the covered list. |
get_treatment_outcomesread-only | External-review outcomes for a treatment: how often insurer denials of this treatment/drug/procedure were overturned by independent reviewers (42,749 published CA IMR decisions, 2001–2026). Accepts a category slug (e.g. 'pharmacy') or specific treatment slug (e.g. 'zepbound', 'speech-therapy'). |
list_insurersread-only | List tracked U.S. health insurers with whether verified CMS-0057-F prior-authorization metrics are available for each. |
rank_denial_ratesread-only | Insurer prior-authorization denial rates (CY2025), ranked only within compatible reporting cohorts. Each row includes its cohort, rank within that cohort, exact source scope, calculation method, and source link. Never compare ranks across cohorts. |
search_outcomesread-only | Search treatments (categories + specific drugs/procedures) and conditions by name. Returns slugs for get_treatment_outcomes / get_condition_outcomes plus headline overturn rates. |
Schemas: list_tools.
{
"name": "com.coverage-rights/coverage-rights",
"$schema": "https://static.modelcontextprotocol.io/schemas/2025-09-29/server.schema.json",
"remotes": [
{
"url": "https://www.coverage-rights.com/api/mcp",
"type": "streamable-http"
}
],
"version": "1.1.0",
"websiteUrl": "https://www.coverage-rights.com/mcp",
"description": "Insurer denial rates, appeal outcomes by treatment and condition, and appeal rights lookups."
}